C3 and polycystic ovary syndrome: CFHR5 is reported to have complement regulatory activities as it binds to heparin and C3b and functions as a cofactor of F-I in C3b cleavage [28], further supporting the concept of hyperactivation of regulatory proteins of the AP in PCOS.